West Pharmaceutical Services, Inc.
WST
$263.51
-$15.59-5.59%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 487.70M | 467.20M | 492.70M | 499.60M | 524.90M |
| Total Depreciation and Amortization | 162.30M | 159.80M | 155.40M | 150.60M | 146.10M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.30M | 0.00 | 2.40M | 45.90M | 50.20M |
| Change in Net Operating Assets | 19.40M | 37.60M | 2.90M | 6.30M | 31.20M |
| Cash from Operations | 676.70M | 664.60M | 653.40M | 702.40M | 752.40M |
| Capital Expenditure | -332.70M | -357.70M | -377.00M | -380.80M | -395.30M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -700.00K | -1.70M | -1.70M | -1.90M | -1.00M |
| Cash from Investing | -333.40M | -359.40M | -378.70M | -382.70M | -396.30M |
| Total Debt Issued | 129.70M | 164.70M | 164.70M | 164.70M | 35.00M |
| Total Debt Repaid | -133.80M | -191.80M | -192.30M | -192.90M | -60.30M |
| Issuance of Common Stock | 18.70M | 20.30M | 32.70M | 32.70M | 47.10M |
| Repurchase of Common Stock | -243.50M | -430.20M | -566.60M | -689.10M | -664.80M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -60.10M | -59.60M | -59.10M | -58.60M | -58.10M |
| Other Financing Activities | -6.20M | -2.00M | -2.00M | -- | -- |
| Cash from Financing | -295.20M | -498.60M | -622.60M | -743.20M | -701.10M |
| Foreign Exchange rate Adjustments | 15.40M | -4.20M | -21.40M | 15.80M | -5.10M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 63.50M | -197.60M | -369.30M | -407.70M | -350.10M |